JBT Marel has climbed sharply over the past month after upbeat profitability news, which puts a fresh spotlight on whether the current share price lines up with the cash the business is expected to generate. With the stock still down over the year as a whole, the key issue is whether this rebound is supported by its underlying cash flows or mostly by changing sentiment.
The stock's next move may depend on whether those higher profitability levels and cash flows are rich enough to justify where JBT Marel now trades.
If you are weighing whether JBT Marel's rebound is fully backed by its cash flows, it can help to compare that question across 32 high quality undervalued stocks.
The Discounted Cash Flow (DCF) approach here evaluates JBT Marel based on the cash it is expected to produce for shareholders. Latest twelve month free cash flow is about $337.2 million, and the model projects free cash flow in the coming years to grow rather than shrink, with 2029 expected at roughly $486 million based on a blend of analyst estimates and extrapolated growth.
Those cash projections are then discounted back to today and compared with the current share price of $126.56. This results in an estimated intrinsic value that is substantially above where the stock trades. Record Q3 margins and raised EPS guidance, along with an expanded $700 million buyback, help explain why the cash flow outlook embedded in the DCF is stronger than the backward looking share chart might suggest. Find out what JBT Marel could be worth using our Discounted Cash Flow (DCF) estimate.
Narratives pick up where JBT Marel's valuation puzzle leaves off by spelling out which paths for growth, profitability and earnings would need to play out for the share price to sit meaningfully above or below today's level, and they are hosted on Simply Wall St's Community page. Rather than a single shortcut number, each one lays out the specific assumptions behind its own idea of fair value so you can compare those inputs with actual results as they arrive.
The two JBT Marel scenarios both rely on the same order book and synergy targets, yet they reach very different conclusions on how much is already priced in.
Bull case: 24% undervalued
According to the analyst consensus Narrative on Simply Wall St, the optimistic view leans heavily on orders, synergies and cash conversion.
"The ongoing global increase in protein consumption and demand for food safety and traceability is driving sustained investment in automation and integrated processing solutions…"
Discover why this Narrative puts JBT Marel at 24% undervalued.
Bear case: 7% overvalued
The bearish analyst Narrative on Simply Wall St emphasizes margin quality, execution risk and scrutiny of reported earnings.
"The Q2 2026 shortfall of roughly US$20 million in Prepared Food & Beverage revenue due to logistics constraints and production inefficiencies from footprint moves suggests integration friction could keep recurring execution gaps…"
Explore why this Narrative puts JBT Marel at 7% overvalued.
Price and cash flow only tell part of what you need to know about JBT Marel, because recent research has highlighted specific risk checks that deserve your attention before you lean on any valuation work. Take a closer look at 1 warning sign before settling on a valuation.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com